Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer. Revenue for the year
Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer.
Revenue for the year ending Dec. 31, 1994, was $68.4 million,compared to $73.3 million in 1993. The company lost $5.6 millionin 1994 after reporting a break-even performance for the previousyear.
Fourth-quarter trends were also down. As revenue fell 5.6%to $18.3 million, Fischer posted a fourth-quarter loss of $980,000,compared to a profit of $462,000 for the same period of 1993.The downturn was attributed principally to delays in anticipatedoriginal equipment manufacturer shipments, caused by customer-requesteddesign changes in 1994, according to the company.
Nields linked Fischer's performance last year with an estimated30% revenue decline in $1 billion domestic diagnostic x-ray equipmentmarket in 1994.
"We believe the market is undergoing a continuing radicalrestructuring as providers and payors realign strategies in acompetitive marketplace," he said.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.